LEXINGTON, Ky.--(BUSINESS WIRE)--Demeetra, a gene editing technologies company, is proud to announce that its research in collaboration with Variation Biosciences, Inc. “VBI” has been selected for an ...
Scientists identified 473 human genes that act as genetic “on/off switches,” shaping disease risk through tissue-specific or universal patterns regulated by DNA changes and hormones. Study: ...
Researchers are uncovering fresh insights into Alzheimer’s disease, from a rare genetic variant that may help the brain resist plaque damage to new blood-based biomarker guidelines aimed at earlier, ...
In vitro data demonstrated self-complementary AAV9 (scAAV9) enabled ~30-fold higher MeCP2 protein expression compared to single-stranded AAV9 (ssAAV9), supporting the ability to effectively deliver ...
An interferon-stimulated genes signature including IFI27 and OAS1, together with complement levels, may reflect the immune state of patients with SLE and identify active disease. An automated ...
Hosted on MSN
Making sense of your gene expression data
Gene expression analysis helps uncover how cells function, adapt, and contribute to disease. Techniques from microarray preprocessing to advanced single-cell proteomics offer complementary insights ...
Using genomic and transcriptional data has greatly improved the understanding of multiple aspects of human physiology. A new paper in PNAS reports on molecular-level associations of co-occurring ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...
Neuronal specification, expansion and differentiation are tightly regulated by the concerted actions of transcription and chromatin modifying factors that are recruited to regulatory elements in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results